Memantine, a long-approved and cost-effective drug used to treat Alzheimer's disease, could also benefit patients with sickle ...

Please provide your email address to receive an email when new articles are posted on . Response rates on the SRS-2 and CGI-S were significantly higher in those given memantine. Memantine was also ...

The dementia drug memantine showed promise for improving social functioning in a small trial of youth with autism. Nine of 16 children and adolescents treated with memantine met the response criteria ...

The drug memantine can benefit patients with moderate to severe Alzheimer's disease, according to a study reported in the April 3 New England Journal of Medicine. The use of memantine for Alzheimer's ...

August 24, 2010 — The adamantine derivative, memantine, preferentially blocks excessive extrasynaptic activity of the N-methyl-D-aspartate (NMDA) subtype of glutamate receptors (NMDAR), while largely ...

The latest clinical practice guideline from the Deprescribing Guidelines for the Elderly Project, based at the Bruyère Research Institute, Ottawa, Canada, focuses on the discontinuation of ...

This release is available in German. There is no scientific proof that patients with moderate or severe Alzheimer's disease benefit from drugs containing the agent memantine. This is the conclusion in ...

Elevated pregenual anterior cingulate cortex levels were associated with a favorable treatment response. HealthDay News — Memantine improves social impairments in youth with autism spectrum disorder ...

(HealthDay News) — The combination of memantine plus sertraline is efficacious for major depressive disorder, according to a study published in the Journal of Clinical Pharmacy and Therapeutics.

Researchers sought to determine whether combining memantine with a cholinesterase inhibitor produced early and consistent improvements in cognition for patients with moderate to severe Alzheimer ...

“A balanced and skillful approach to life, taking care to avoid extremes, becomes a very important factor in conducting one's everyday existence. It is important in all aspects of life.” —The Dalai ...

Memantine, a long-approved and cost-effective drug used to treat Alzheimer’s disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international ...